John Porter

John Porter Advocating science from inside the House By Andrea Gawrylewski © Jordan Domont In 1995 when the Republicans took over the US House of Representatives, times were tight for the Appropriations Subcommittee for Labor, Health and Human Services, and Education, which allocates funds to the National Institutes of Health. Under a new budget resolution, the House budget committee told John Porter, then subcommittee chair, he needed to shave

Written byAndrea Gawrylewski
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

By Andrea Gawrylewski

In 1995 when the Republicans took over the US House of Representatives, times were tight for the Appropriations Subcommittee for Labor, Health and Human Services, and Education, which allocates funds to the National Institutes of Health. Under a new budget resolution, the House budget committee told John Porter, then subcommittee chair, he needed to shave 5% from the National Institutes of Health budget each year for the next five years. "I thought it was insane," Porter recalls one June afternoon from behind his imposing mahogany desk at Hogan and Hartson, a law firm in Washington, DC.

He quickly gathered a group of 10 Nobel laureates, CEOs of pharmaceutical companies, and members of the Federation of American Scientists for Biomedical Research to convince Newt Gingrich, Speaker of the House, to stop cutting the NIH budget and instead to give the agency a boost. "Newt gave us one hour, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo